A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging

• Published in: BMC cancer Vol. 15; no. 1; p. 566
• Main Authors: Lee, Joo Yong, Cho, Kang Su, Kang, Dong Hyuk, Jung, Hae Do, Kwon, Jong Kyou, Oh, Cheol Kyu, Ham, Won Sik, Choi, Young Deuk
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 01.08.2015; BioMed Central
• Subjects: Aminolevulinic Acid - analogs & derivatives; Aminolevulinic Acid - metabolism; Bladder cancer; Cancer; Comparative analysis; Cystoscopy - methods; Humans; Image Interpretation, Computer-Assisted - methods; Meetings; Narrow Band Imaging - methods; Oncology, Experimental; Photosensitizing Agents - metabolism; Political aspects; Randomized Controlled Trials as Topic; Technology; Treatment Outcome; Urinary Bladder Neoplasms - metabolism; Urinary Bladder Neoplasms - pathology; Urinary Bladder Neoplasms - surgery
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-015-1571-8

This study included a network meta-analysis of evidence from randomized controlled trials (RCTs) to assess the therapeutic outcome of transurethral resection (TUR) in patients with non-muscle-invasive bladder cancer assisted by photodynamic diagnosis (PDD) employing 5-aminolaevulinic acid (5-ALA) or hexylaminolevulinate (HAL) or by narrow band imaging (NBI). Relevant RCTs were identified from electronic databases. The proceedings of relevant congresses were also searched. Fifteen articles based on RCTs were included in the analysis, and the comparisons were made by qualitative and quantitative syntheses using pairwise and network meta-analyses. Seven of 15 RCTs were at moderate risk of bias for all quality criteria and two studies were classified as having a high risk of bias. The recurrence rate of cancers resected with 5-ALA-based PDD was lower than of those resected using HAL-based PDD (odds ratio (OR) = 0.48, 95 % confidence interval (CI) [0.26-0.95]) but was not significantly different than those resected with NBI (OR = 0.53, 95 % CI [0.26-1.09]). The recurrence rate of cancers resected using HAL-based PDD versus NBI did not significantly differ (OR = 1.11, 95 % CI [0.55-2.1]). All cancers resected using 5-ALA-based PDD, HAL-based PDD, or NBI recurred at a lower rate than those resected using white light cystoscopy (WLC). No difference in progression rate was observed between cancers resected by all methods investigated. The recurrence rate of some bladder cancers can be decreased by the implementation of either PDD- and NBI-assisted TUR; in real settings, clinicians should consider replacing WLC as the standard imaging technology to guide TUR.